BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the 20 Best Investments in 2026. BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is next on our list. TheFly reported on February 18 that Wells Fargo & Company increased its price target for BMRN from $70 to $75 while keeping an Overweight rating. The firm believes the upcoming Transcon-CNP PDUFA may mark the final negative catalyst for BMRN, and its sum ...

Core Points - Corporación Inmobiliaria Vesta, S.A.B. de C.V. announced the closing of US$ 500 million in senior unsecured notes with a 5.500% interest rate due in 2033 [1] - The issuance received a credit rating of BBB-/Positive from both S&P Global Ratings and Fitch Ratings [1] Company Summary - Vesta is a fully-integrated, internally managed real estate company focused on owning, managing, developing, and leasing industrial properties in Mexico [1]